Sachi Bioworks Inc

AmideBio LLC, located in Louisville, CO, is a leading biotechnology company specializing in the development of novel peptides for targeting metabolic diseases. With a focus on drug discovery and custom synthesis, AmideBio offers a wide range of peptide products and services to meet the needs of the pharmaceutical industry. Driven by a commitment to innovation and collaboration, AmideBio is dedicated to providing high-quality peptides that address the growing demand for effective treatments in the field of metabolic disease. With a team of experienced professionals and state-of-the-art facilities, AmideBio is at the forefront of peptide research and development, offering cutting-edge solutions to improve patient outcomes.Generated from the website

Sudhin Biopharma Co, located in Louisville, CO, specializes in innovative bioprocessing devices, including various sizes of BioSettlers designed for applications in cell culture and product recovery. Their technology is particularly effective in enhancing cell retention in perfusion bioreactors and clarifying cell culture broth to recover valuable products such as antibodies and AAV vectors. With a focus on advancing cell therapy applications, Sudhin's Single Use BioSettler is being tested for its efficacy in harvesting and concentrating cell therapy products, including CART cells and islet cells for diabetes treatment. The company is committed to developing solutions that optimize cell culture parameters and improve overall bioprocessing efficiency. Generated from the website

Bolder Biotechnology Inc., based in Boulder, Colorado, specializes in advanced protein engineering to develop innovative, cost-effective protein therapeutics aimed at improving patient outcomes. Their diversified product pipeline includes treatments for a range of health conditions, including hematological and endocrine disorders, cancer, and infectious diseases. The company employs proprietary technologies such as Site-Specific PEGylation and ImmunoFusion Protein technology to enhance the efficacy and longevity of their therapeutic products. Additionally, Bolder Biotechnology is actively engaged in bio-defense initiatives supported by the U.S. government, focusing on developing treatments for acute radiation syndrome and other critical health challenges. Generated from the website